Elutia Inc.

General ticker "ELUT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $75.4M (TTM average)

Elutia Inc. does not follow the US Stock Market performance with the rate: -29.1%.

Estimated limits based on current volatility of 9.3%: low 0.52$, high 0.63$

Factors to consider:

  • Total employees count: 54 as of 2023
  • Current price 76.5% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.49$, 6.44$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.04$, 5.44$]

Financial Metrics affecting the ELUT estimates:

  • Positive: with PPE of -1.6 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -19.18 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Positive: Inventory ratio change, % of 0.35 <= 0.84
  • Positive: Investing cash flow per share per price, % of -0.40 > -0.66
  • Negative: negative Net income
  • Negative: Shareholder equity ratio, % of -128.05 <= 18.93
  • Negative: Industry earnings per price (median), % of -16.34 <= 0

Similar symbols

Short-term ELUT quotes

Long-term ELUT plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $23.85MM $24.75MM $24.38MM
Operating Expenses $59.04MM $55.27MM $60.03MM
Operating Income $-35.19MM $-30.53MM $-35.65MM
Non-Operating Income $-0.96MM $-10.70MM $-18.47MM
Interest Expense $5.12MM $5.80MM $4.78MM
R&D Expense $7.73MM $4.40MM $3.79MM
Income(Loss) $-36.15MM $-41.22MM $-54.12MM
Taxes $0.03MM $0.03MM $0.01MM
Profit(Loss)* $-32.90MM $-37.66MM $-53.95MM
Stockholders Equity $-5.03MM $-38.60MM $-46.26MM
Inventory $4.24MM $3.85MM $3.91MM
Assets $68.84MM $43.43MM $36.13MM
Operating Cash Flow $-21.43MM $-21.76MM $-22.66MM
Capital expenditure $0.54MM $0.35MM $0.65MM
Investing Cash Flow $-0.54MM $14.21MM $-0.47MM
Financing Cash Flow $8.54MM $9.84MM $17.09MM
Earnings Per Share** $-2.38 $-2.07 $-1.86

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.